摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N-[1-(2-chloro-4-fluoro-phenyl)-1H-pyrazol-3-yl]-2-((7S,8aR)-3-oxo-hexahydro-oxazolo[3,4-a]pyridin-7-yl)-acetamide | 1226593-92-5

中文名称
——
中文别名
——
英文名称
N-[1-(2-chloro-4-fluoro-phenyl)-1H-pyrazol-3-yl]-2-((7S,8aR)-3-oxo-hexahydro-oxazolo[3,4-a]pyridin-7-yl)-acetamide
英文别名
2-[(7S,8aR)-3-oxo-1,5,6,7,8,8a-hexahydro-[1,3]oxazolo[3,4-a]pyridin-7-yl]-N-[1-(2-chloro-4-fluorophenyl)pyrazol-3-yl]acetamide
N-[1-(2-chloro-4-fluoro-phenyl)-1H-pyrazol-3-yl]-2-((7S,8aR)-3-oxo-hexahydro-oxazolo[3,4-a]pyridin-7-yl)-acetamide化学式
CAS
1226593-92-5
化学式
C18H18ClFN4O3
mdl
——
分子量
392.817
InChiKey
MNHDAVCFXOJUOO-WCQYABFASA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.6
  • 重原子数:
    27
  • 可旋转键数:
    4
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.39
  • 拓扑面积:
    76.5
  • 氢给体数:
    1
  • 氢受体数:
    5

文献信息

  • BIOLOGICALLY ACTIVE AMIDES
    申请人:Peterson John Matthew
    公开号:US20110230497A1
    公开(公告)日:2011-09-22
    The present invention is directed to biologically active amides which are ligands at the NPY Y5 receptor. The invention further provides a pharmaceutical composition comprising a therapeutically effective amount of a compound of the invention and a pharmaceutically acceptable carrier. This invention also provides a method of treating a subject suffering from certain disorders which comprises administering to the subject an amount of a compound of the subject invention. Furthermore, this invention also provides uses of a compound of the invention for the manufacture of a medicament for treating a subject suffering from certain disorders.
    本发明涉及生物活性酰胺,其是NPY Y5受体的配体。该发明还提供了一种制药组合物,包括本发明化合物的治疗有效量和药学可接受载体。本发明还提供了治疗患有某些疾病的受试者的方法,包括向受试者投予本发明化合物的量。此外,本发明还提供了一种利用本发明化合物制造治疗患有某些疾病的受试者的药物的用途。
  • [EN] BIOLOGICALLY ACTIVE AMIDES<br/>[FR] AMIDES BIOLOGIQUEMENT ACTIFS
    申请人:LUNDBECK & CO AS H
    公开号:WO2010053861A2
    公开(公告)日:2010-05-14
    The present invention is directed to biologically active amides which are ligands at the NPY Y5 receptor. The invention further provides a pharmaceutical composition comprising a therapeutically effective amount of a compound of the invention and a pharmaceutically acceptable carrier. This invention also provides a method of treating a subject suffering from certain disorders which comprises administering to the subject an amount of a compound of the subject invention. Furthermore, this invention also provides uses of a compound of the invention for the manufacture of a medicament for treating a subject suffering from certain disorders.
查看更多